From Diagnosis to Cure: Exploring Technological Advancements in Non-Invasive Diagnostics Propelling the Growth of the NAFLD Market.
The journey to effective management of Non-Alcoholic Fatty Liver Disease (NAFLD) begins with accurate diagnosis, particularly the staging of fibrosis, which is the strongest predictor of clinical outcomes. For decades, the gold standard for this was the liver biopsy. However, the biopsy's invasiveness, risk of complications, sampling error, and high cost made it unsuitable for screening the...
0 Комментарии 0 Поделились 11 Просмотры 0 предпросмотр